Literature DB >> 30224292

Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States.

Eli S Rosenberg1, Julia L Marcus2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30224292      PMCID： PMC6417495          DOI： 10.1016/j.annepidem.2018.08.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN： 1047-2797            Impact factor:   6.996


× No keyword cloud information.
  27 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Challenges in Translating PrEP Interest Into Uptake in an Observational Study of Young Black MSM.

Authors:  Charlotte-Paige Rolle; Eli S Rosenberg; Aaron J Siegler; Travis H Sanchez; Nicole Luisi; Kevin Weiss; Scott Cutro; Carlos Del Rio; Patrick S Sullivan; Colleen F Kelley
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

3.  Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.

Authors:  Jeffrey T Parsons; H Jonathon Rendina; Jonathan M Lassiter; Thomas H F Whitfield; Tyrel J Starks; Christian Grov
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

4.  Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Jeremy Grey
Journal:  Ann Epidemiol       Date:  2018-05-18       Impact factor: 3.797

5.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

6.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Improving Estimation of HIV Viral Suppression in the United States: A Method to Adjust HIV Surveillance Estimates From the Medical Monitoring Project Using Cohort Data.

Authors:  Eli S Rosenberg; Heather Bradley; Kate Buchacz; Jennie McKenney; Gabriela Paz-Bailey; Joseph Prejean; John T Brooks; Luke Shouse; Patrick S Sullivan
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

8.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

9.  Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures.

Authors:  Julia L Marcus; Leo B Hurley; Dong Phuong Nguyen; Michael J Silverberg; Jonathan E Volk
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321
View more
  10 in total

1.  Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out.

Authors:  Julia L Marcus; A David Paltiel; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

2.  Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Authors:  Teaniese L Davis; Mona Mittal; Adanna C Oragwu; Min Qi Wang; Bradley O Boekeloo
Journal:  AIDS Behav       Date:  2022-09-12

3.  Association of Race and Other Social Determinants of Health With HIV Pre-Exposure Prophylaxis Use: A County-Level Analysis Using the PrEP-to-Need Ratio.

Authors:  Ryan Doherty; Jennifer L Walsh; Katherine G Quinn; Steven A John
Journal:  AIDS Educ Prev       Date:  2022-06

4.  Estimated Number of Men Who Have Sex With Men With Indications for HIV Pre-exposure Prophylaxis in a National Sexual Network Study.

Authors:  Kevin M Weiss; Pragati Prasad; Ramya Ramaraju; Maria Zlotorzynska; Samuel M Jenness
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

5.  Projecting the impact of equity-based preexposure prophylaxis implementation on racial disparities in HIV incidence among MSM.

Authors:  William C Goedel; S Bessey; Mark N Lurie; Katie B Biello; Patrick S Sullivan; Amy S Nunn; Brandon D L Marshall
Journal:  AIDS       Date:  2020-08-01       Impact factor: 4.632

6.  Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.

Authors:  Daniel Were; Abednego Musau; Jane Mutegi; Patricia Ongwen; Griffins Manguro; Mercy Kamau; Tom Marwa; Hellen Gwaro; Irene Mukui; Marya Plotkin; Jason Reed
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

7.  Global implementation of PrEP for HIV prevention: setting expectations for impact.

Authors:  Maria N Pyra; Jessica E Haberer; Nina Hasen; Jason Reed; Nelly R Mugo; Jared M Baeten
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

8.  Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015-2018).

Authors:  Darrell H S Tan; Thomas M Dashwood; James Wilton; Abigail Kroch; Tara Gomes; Diana Martins
Journal:  Can J Public Health       Date:  2020-06-11

9.  High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda.

Authors:  Victor Ssempijja; Gertrude Nakigozi; Robert Ssekubugu; Joseph Kagaayi; Godfrey Kigozi; Fred Nalugoda; Betty Nantume; James Batte; Grace Kigozi; Ping Teresa Yeh; Hadijja Nakawooya; David Serwadda; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Kate M Grabowski; Larry W Chang; Anja Van't Hoog; Frank Cobelens; Steven J Reynolds
Journal:  J Acquir Immune Defic Syndr       Date:  2022-03-08       Impact factor: 3.771

10.  Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women's Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States.

Authors:  Morgan M Philbin; Carrigan Parish; Elizabeth N Kinnard; Sarah E Reed; Deanna Kerrigan; Maria L Alcaide; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Margaret Fischl; Lisa R Metsch
Journal:  AIDS Behav       Date:  2021-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.